1/24/2025NMPA Issues Announcement on Expanding the Implementation Scope of the...

1/24/2025NHSA Solicits Information on Low-Transaction Drugs in the National Dru...

1/24/2025Snapshot of BMI System Financial Performance in 2024

1/24/2025Recent Executive Moves

1/23/2025CDE Issues the Guidelines for Writing Clinical-Related Information in ...

1/23/2025CDE Issues the Technical Guidelines for Pharmaceutical Studies of Monk...

1/23/2025CDE Issues the Technical Guidelines for Non-Clinical Research of Proph...

1/23/2025Belief BioMed Announces IND Clearance by FDA for DMD Gene Therapy Cand...

1/23/2025TargetRx Secures $50 Million in Series C Financing to Propel Global Cl...

1/22/2025Qyuns Thera Secures CSRC Approval for Full H-share Circulation

1/22/2025Shanghai Bao Pharma Files for IPO on HKSE

1/22/2025YolTech to Initiate a Clinical Trial of FIC Bone Marrow-Targeted In V...

1/22/2025Innovent Advances PD-1/IL-2α-Bias Bispecific Antibody IBI363 into Pha...

1/22/2025Fosun Pharma’s Bid to Privatize Henlius Fails After Shareholder Rejec...

1/22/2025Imbioray Secures Series A+ Financing to Advance NK Cell Therapy Pipeli...

1/22/2025Degron Secures $20M in Series A+ Financing to Advance Molecular Glue T...

1/22/2025CDE Issues the Technical Guideline for the Study of Storage Period for...

1/22/2025NHSA Issues the Notice on Establishing BMI Data Working Groups to Bett...

1/21/2025NMPA Approves Two Homegrown Oncology Therapies for Lung and Ovarian Ca...

1/21/2025IVIEW Thera Completes Series A++ Financing to Advance Ophthalmology Pi...

1/21/2025Fermion and Simcere Join Forces to Develop Non-Opioid Analgesic 

1/21/2025China to Solicit Feedbacks on Improving Centralized Drug Procurement ...

1/21/2025Zai Lab's NDA for Schizophrenia Treatment KarXT Accepted in China

1/21/2025CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in Inve...

1/21/2025NiKang Does First Patient in a Phase 1b/2 Study of NKT2152 in Combo fo...

1/21/2025 China-based Ascentage Pharma Targets $149M in US IPO

1/21/2025Sichuan Biokin Refiles for Hong Kong IPO Following Lapsed Application

1/21/2025ArriVent Enters Exclusive License with Lepu Biopharma for MRG007, an A...

1/21/2025China's BMI Fund Reports Balanced Budget and Surplus for 2024

1/21/2025China's Biopharma R&D Expands Global Influence in 2024

Page:16/764 Total number of articles:22895: [First][<<] [14] [15] [16] [17] [18] [>>] [End]